News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
11 16 2020 Collaboration will include COVID-19 IgG antibody testing for up to 1,000 study participantsBOSTON, NEW YORK, SECAUCUS, NJ- Nov. 16, 2020 - Today, Dana-Farber Cancer Institute, one of the world’s leading centers of cancer research and treatment, and Quest Diagnostics, (NYSE: DGX), the...
-
11 03 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Credit Suisse 29th Annual Virtual...
-
10 27 2020 First collaboration of virtual care provider and national laboratory provider features self-collected at-home specimen collection and mental health care support to empower diverse workforces to access health care safelyQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Catapult Health, the leading national provider of employer-sponsored Preventive Checkups, have...
-
10 22 2020 - Third quarter revenues of $2.79 billion, up 42.5% from 2019Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2020....
-
10 15 2020 Largest nationally representative study based on laboratory data shows double-digit increases in mixing of fentanyl with amphetamines and cocaineA new Quest Diagnostics Health Trends study indicates that misuse of fentanyl, heroin and nonprescribed opioids are on the rise, potentially due to the COVID-19 pandemic's impact on healthcare...
-
10 15 2020 Quest Diagnostics Recognized for Offering One of the Nation's Best Workforce Health and Well-being Initiatives for Third Year in a RowQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received the 2020 Best Employers: Excellence in Health & Well-Being...
-
10 13 2020 Qualified residents in close proximity to Cheektowaga Walmart may be able to receive at-home self-collection kits by drone deliveryCHEEKTOWAGA, NY – Oct. 13 –Walmart, Quest Diagnostics, and DroneUp today announced a pilot program to provide drone delivery of COVID-19 at-home self-collection kits to single-family homes in...
-
10 05 2020 Nationwide Collaboration Creates Multi-Layered Approach to Public Health SafetyToday, CLEAR, the secure identity company, and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced a new collaboration that aims to foster...
-
09 30 2020 Nearly 20 Viral and Bacterial Infections Can Be Identified from a Single Swab, Reducing Time to Diagnose and TreatHealthcare providers across the United States can now access three different test options from Quest Diagnostics (NYSE: DGX) to aid the diagnosis of COVID-19 and differentiate it from other...
-
09 22 2020 Qualified residents in close proximity to North Las Vegas Walmart may be able to receive at-home self-collection kits by drone deliveryNORTH LAS VEGAS, NV – Sept. 22 –Walmart, Quest Diagnostics, and DroneUp today announced a pilot program to provide drone delivery of COVID-19 at-home self-collection kits to single-family...
09 17 2020 QuestDirect™ Active Infection allows individuals to collect a specimen at home or by drive-thru at more than 500 Walmart Neighborhood Market locationsIndividuals can now purchase a test to diagnose COVID-19 online, without visiting a doctor's office, through QuestDirect, the consumer-initiated testing business of Quest Diagnostics (NYSE: DGX),...
-
09 11 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley 18th Annual Global...
-
09 10 2020 - Revenues for full year 2020 now expected to be $8.4-8.8 billion compared to the previous outlook of $8.0-8.6 billionQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today updated its financial outlook for full year 2020. Since the company reported its...
-
09 02 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Wells Fargo Virtual Healthcare...
08 25 2020 Marijuana positivity climbed by double digits across nearly all employee testing categories, while opiate and heroin positivity declineThe rate of workforce drug positivity hit a sixteen-year high in 2019, according to a new analysis released today by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic...
-
08 24 2020 Quest to dedicate more than $100 million to expand access to testing, partner to help those hit hardest by COVID-19 and fund Foundation initiativesQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, and the Quest Diagnostics Foundation, today announced a wide-ranging initiative to...
-
08 18 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.56 per share,...
-
08 12 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today released its Annual Environmental, Social & Governance Report for 2019. The...
08 03 2020 Next generation sequencing offers more comprehensive data on more commonly inherited health conditionsA new innovation in advanced genetic sequencing automation from Quest Diagnostics (NYSE: DGX) will now enable individuals to access highly accurate genetic testing providing insights into...
07 29 2020 Technique to increase COVID-19 molecular diagnostic testing capacity and provide faster test results reportingQuest Diagnostics (NYSE:DGX) today announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for a new laboratory technique that speeds the process...
-
07 23 2020 - Second quarter revenues of $1.83 billion, down 6.4% from 2019Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2020, which are...
07 18 2020 First FDA authorization of laboratory technique for use in COVID-19 diagnostic testingQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received emergency use authorization (EUA) from the U.S. Food and Drug...
-
07 13 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today preliminary financial results for the second quarter ended June 30,...
-
06 30 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, marks its 10-year anniversary as a CEO Cancer Gold Standard™ employer this year, signifying its...
-
05 29 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies Virtual Healthcare Conference....